157 related articles for article (PubMed ID: 38310584)
1. The Association Between Short-Acting β
Price D; Jenkins C; Hancock K; Vella R; Heraud F; Le Cheng P; Murray R; Beekman M; Bosnic-Anticevich S; Botini F; Carter V; Catanzariti A; Doan J; Fletton K; Kichkin A; Le T; Le Lievre C; Lau CM; Novic D; Pakos J; Ranasinghe K; Roussos A; Samuel-King J; Sharma A; Stewart D; Willet B; Bateman E;
Adv Ther; 2024 Mar; 41(3):1262-1283. PubMed ID: 38310584
[TBL] [Abstract][Full Text] [Related]
2. Over-prescription of short-acting β
Chakaya J; Mecha J; Beekman M
BMC Prim Care; 2023 Jul; 24(1):141. PubMed ID: 37422638
[TBL] [Abstract][Full Text] [Related]
3. Over-prescription of short-acting β
Smith C; Ambaram A; Mitha E; Abdullah I; Abdullah IA; Reddy J; Trokis J; Ramlachan P; Govind U; Lightfoot K; Moodley K; Smit R; Beekman MJHI
Afr J Thorac Crit Care Med; 2022; 28(4):. PubMed ID: 36874189
[TBL] [Abstract][Full Text] [Related]
4. Short-acting β
Yorgancıoğlu A; Aksu K; Naycı SA; Ediger D; Mungan D; Gül U; Beekman MJHI;
BMC Pulm Med; 2022 Jun; 22(1):216. PubMed ID: 35655251
[TBL] [Abstract][Full Text] [Related]
5. Greenhouse Gas Emissions from Respiratory Treatments: Results from the SABA CARBON International Study.
Alzaabi A; Bell JP; Montero-Arias F; Price DB; Jackson DJ; Wang HC; Budgen N; Farouk H; Maslova E
Adv Ther; 2023 Nov; 40(11):4836-4856. PubMed ID: 37684493
[TBL] [Abstract][Full Text] [Related]
6. Overprescription of short-acting β
Al Zaabi A; Busaidi N; Al Mutairy S; Yorgancıoğlu A; Aksu K; Al-Jahdali H; Wali S; Elsayed M; Beekman MJ
Expert Rev Respir Med; 2022 Jul; 16(7):833-847. PubMed ID: 35848074
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of overuse of short-acting beta-2 agonists (SABA) and associated factors among patients with asthma in Germany.
Worth H; Criée CP; Vogelmeier CF; Kardos P; Becker EM; Kostev K; Mokros I; Schneider A
Respir Res; 2021 Apr; 22(1):108. PubMed ID: 33863317
[TBL] [Abstract][Full Text] [Related]
8. Short-acting β2-agonists over-prescription in patients with asthma: an Indian subset analysis of international SABINA III study.
Modi M; Mody K; Jhawar P; Sharma L; Padukudru Anand M; Gowda G; Mendiratta M; Kumar S; Nayar S; Manchanda M; Kumari Badam A; Singh M; Siddiqui W; Beekman M
J Asthma; 2023 Jul; 60(7):1347-1358. PubMed ID: 36519934
[TBL] [Abstract][Full Text] [Related]
9. Understanding reliever overuse in patients purchasing over-the-counter short-acting beta
Azzi EA; Kritikos V; Peters MJ; Price DB; Srour P; Cvetkovski B; Bosnic-Anticevich S
BMJ Open; 2019 Aug; 9(8):e028995. PubMed ID: 31412998
[TBL] [Abstract][Full Text] [Related]
10. Short-acting beta-2 agonist prescription patterns and clinical outcomes in Chinese patients with asthma: an observational study in mainland China for the SABINA programme.
Bao W; Zhang Y; Hang J; Guo Y; Tang W; Yun C; Deng J; Jin M; Lai K; Yu H; Beekman M; Zhou X; Zhang M
Ther Adv Respir Dis; 2022; 16():17534666221115054. PubMed ID: 36065527
[TBL] [Abstract][Full Text] [Related]
11. Over-prescription of short-acting β
Alzaabi A; Al Busaidi N; Pradhan R; Shandy F; Ibrahim N; Ashtar M; Khudadah K; Hegazy K; Samir M; Negm M; Farouk H; Al Khalidi A; Beekman M
Asthma Res Pract; 2022 Jul; 8(1):3. PubMed ID: 35799290
[TBL] [Abstract][Full Text] [Related]
12. Short-acting β
Theerakittikul T; Nakwan N; Niyompattama A; Siriphan P; Beekman MJHI
J Asthma; 2023 Dec; 60(12):2177-2188. PubMed ID: 37405933
[TBL] [Abstract][Full Text] [Related]
13. Over-prescription of short-acting β
Montero-Arias F; Garcia JCH; Gallego MP; Antila MA; Schonffeldt P; Mattarucco WJ; Gallegos LFT; Beekman MJHI
J Asthma; 2023 Mar; 60(3):574-587. PubMed ID: 35670783
[TBL] [Abstract][Full Text] [Related]
14. SABA Overuse in Russia - Burden and Possible Causes: An Analysis of the Russian Population in the SABINA III (SABA use IN Asthma) Study.
Avdeev S; Voznesenskiy N; Boldina M; Ignatova G; Kostina N; Kulbaisov A; Leshchenko I; Beekman MJHI
J Asthma Allergy; 2022; 15():371-379. PubMed ID: 35368426
[TBL] [Abstract][Full Text] [Related]
15. Short-acting β
Bateman ED; Price DB; Wang HC; Khattab A; Schonffeldt P; Catanzariti A; van der Valk RJP; Beekman MJHI
Eur Respir J; 2022 May; 59(5):. PubMed ID: 34561293
[TBL] [Abstract][Full Text] [Related]
16. Short-acting β
Ban AY; Vengadasalam P; Taher SW; Mohd Zim MA; Sirol Aflah SS; Daut UN; Hyder Ali IA; Pereirasamy L; Omar A; Ibrahim A; Mohd Tarekh NA; Chan SK; Ali N; Mohd Isa NA; Hussain H; Abdul Karim N; Raja Gopal V; Chiam SY; Beekman MJHI
Malays Fam Physician; 2023; 18():32. PubMed ID: 37292227
[TBL] [Abstract][Full Text] [Related]
17. SABINA: An Overview of Short-Acting β
Janson C; Menzies-Gow A; Nan C; Nuevo J; Papi A; Quint JK; Quirce S; Vogelmeier CF
Adv Ther; 2020 Mar; 37(3):1124-1135. PubMed ID: 31981105
[TBL] [Abstract][Full Text] [Related]
18. Predictors of excessive short-acting β
Kupczyk M; Barg W; Bochenek G; Brożek G; D Browiecki P; Brzostek D; D Browski A; Dobek R; Gawlik R; Kucharczyk A; Kupryś-Lipińska I; Mastalerz-Migas A; Kowalski ML
Postepy Dermatol Alergol; 2023 Dec; 40(6):790-797. PubMed ID: 38282873
[TBL] [Abstract][Full Text] [Related]
19. Short-acting β2-agonist prescriptions in patients with asthma: findings from the South Korean cohort of SABINA III.
Yoo KH; Kim SH; Kim SH; Moon JY; Park HW; Chang YS; Beekman MJHI
Korean J Intern Med; 2024 Jan; 39(1):123-136. PubMed ID: 38057957
[TBL] [Abstract][Full Text] [Related]
20. SABINA + Hong Kong: a territory wide study of prescribing trends and outcomes associated with the use of short-acting β2 agonists in the Chinese population.
Fung LW; Yan VK; Kwan C; Kwok WC; Lam DC; McDonald CF; Bloom CI; Wong IC; Chan EW
BMC Pulm Med; 2024 May; 24(1):232. PubMed ID: 38745268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
